What happens when my Variant of Uncertain Significance is reclassified?
References
1. Ambry Genetics. Patient for Life Program . Retrieved from https://www.ambrygen.com/providers/patient-for-life
2. ARUP Laboratories. Bombard et al. Recontacting patients in clinical genetics services: a shared responsibility . Genetics
in Medicine. 2019. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460896/
3. Blueprint Genetics. VUS Clarification Program . Retrieved from https://blueprintgenetics.com/vus-clarification/
4. Fulgent Genetics. Reclassification Policy . Retrieved from
https://web.fulgentgenetics.com/resources/testing-with-fulgent/reclassification-policy
5. Invitae / Labcorp. Follow-up Testing & Re-requisition Service . Retrieved from
https://www.invitae.com/en/providers/follow-up-testing
6. Myriad Genetics. Variant Reclassification Blog . Retrieved from
https://myriad.com/oncology/myriad-genetics-blog/variant-reclassification/
7. Color Health. Contact & Policy Inquiries . Retrieved from https://www.color.com/contact-us
8. GeneDx. Variant Testing Programs . Retrieved from https://www.genedx.com/variant-testing-programs/
9. PreventionGenetics. Re-analysis Policy . Retrieved from
https://www.preventiongenetics.com/ClinicalTesting/re-analysis-policy
10. Natera. General Contact for Policy Details . Retrieved from https://www.natera.com/company/contact-us